TRANSFORMED MYCOSIS FUNGOIDES
Clinical trials for TRANSFORMED MYCOSIS FUNGOIDES explained in plain language.
Never miss a new study
Get alerted when new TRANSFORMED MYCOSIS FUNGOIDES trials appear
Sign up with your email to follow new studies for TRANSFORMED MYCOSIS FUNGOIDES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo therapy hopes to tackle rare skin cancer
Disease control TerminatedThis phase II trial tests whether combining a targeted antibody drug (mogamulizumab) with a procedure that treats white blood cells with light (extracorporeal photopheresis) can better control erythrodermic cutaneous T-cell lymphoma, a rare skin cancer. About 34 adults with advan…
Matched conditions: TRANSFORMED MYCOSIS FUNGOIDES
Phase: PHASE2 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Aug 15, 2026 00:00 UTC
-
Engineered donor cells take aim at tough blood cancers in early trial
Disease control TerminatedThis early-phase trial tests a new type of immune cell therapy called WU-CART-007 for people with certain blood cancers, including acute myeloid leukemia and T-cell lymphoma, that have come back or not responded to treatment. The therapy uses donor cells that are genetically modi…
Matched conditions: TRANSFORMED MYCOSIS FUNGOIDES
Phase: PHASE1 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated Jul 23, 2026 00:00 UTC